NCT01571063已完成2 期
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 2
- 主要终点
- Change from Baseline in serum alanine aminotransferase levels at week 48
研究概览
简要总结
Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters.
- Trial with medicinal product
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Vitamin D3
Experimental
干预措施: Vitamin D3 (Drug)
Vitamin D3
Experimental
干预措施: Placebo (Drug)
Placebo
Placebo Comparator
干预措施: Vitamin D3 (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Change from Baseline in serum alanine aminotransferase levels at week 48
时间窗: Measurement at week 0 and week 48
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-MebrofeninNon-alcoholic SteatohepatitisNCT02235233University of North Carolina, Chapel Hill21
招募中
2 期
Digoxin In NASH (CODIN)Fatty Liver DiseaseNASHNCT06588699Yale University144
已完成
3 期
Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 DiabetesNASHDiabetes Mellitus, Type 1NCT06348706Ain Shams University60
进行中（未招募）
不适用
Fibrosis Reduction in Non Alcoholic SteatohepatitisNASH With FibrosisWeight LossBariatric Surgery CandidateNCT05798702Fondazione Policlinico Universitario Agostino Gemelli IRCCS20
已完成
4 期
Vitamin D in Fatty Liver DiseaseNon-alcoholic Fatty Liver DiseaseVitamin D DeficiencyNCT04038853University Hospital Rijeka360